Sushil Kumar

Sushil Kumar

Auto-generated profile, based on publicly available information

Sushil Kumar

School of Pharmaceutical Sciences, Faculty of Pharmacy, IFTM University, Moradabad, Uttar Pradesh, INDIA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
SVShweta Verma
Shweta Verma
SKSurendra Kumar
Surendra Kumar
SKSushil Kumar
Sushil Kumar

1 December 2024 in Central Nervous System Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SHShivam
Shivam
AGAsheesh Kumar Gupta
Asheesh Kumar Gupta
SKSushil Kumar
Sushil Kumar
: One of the most crippling effects of diabetes mellitus is diabetic neuropathy, which can cause discomfort, loss of movement, and even amputation. Diabetic neuropathy manifests in a variety of ways, ranging from pain to death. Diagnosing diabetic neuropathy can be challenging since it often goes unnoticed for many years following the onset of diabetes. In addition to oxidative stress in neurons, hyperglycemia activates a number of metabolic pathways that are important sources of damage and possible targets for treatment in diabetic neuropathy. Downstream metabolic cascades caused by prolonged hyperglycemia include activation of protein kinase C, increased production of advanced glycation end products, excessive release of cytokines, increased oxidative stress, and injury to peripheral nerves. Despite the fact that these metabolic anomalies are considered the main cause of diabetes-related microvascular issues, the diverse mechanistic processes of neuropathy are characterized by organ-specific histological and biochemical features. Although the symptoms of diabetic neuropathy can be treated, there are few options to correct the underlying problem. Diabetic neuropathy exerts a tremendous financial, psychological, and physical burden on society, emphasizing the need for efficient and focused treatment. The major goal of this review is to shed light on the multiple mechanisms and pathways that contribute to the onset of diabetic neuropathy and to provide readers with a comprehensive understanding of emerging therapeutic strategies to postpone or reverse various forms of diabetic neuropathy. The article discusses available medications and provides the latest guidelines for the treatment of pain and distal symmetric polyneuropathy, including diabetic autonomic neuropathy, which may help the patients control pain well and assess alternatives for treatment that might be more successful in preventing or delaying the course of a disease.

1 January 2023 in Current Drug Discovery Technologies
Verified
Journal Article
Closed access
PDF file
PSPooja Saini
Pooja Saini
ZRZia Ur Rehman
Zia Ur Rehman
SKSushil Kumar
Sushil Kumar
Aim: The present research work aims to prepare a series of 1-(4-(2-(1H-indol-1-yl)-2- oxoethoxy)phenyl)-3-phenylprop-2-en-1-one derivatives. Method: The major compound was achieved by the reaction of indole with chloroacetylchloride in benzene afforded 2-chloro-1-(indoline-1-yl) ethanone which reacts o- hydroxy acetophenone in presence of acetonitrile to form 2-(4-acetylphenoxy)-1-(1H-indol-1-yl)ethan-1-one then goes through aldol condensation to give various final derivatives. Results and conclusion: After the synthesis of compounds, the synthesized compounds were characterized by checking their solubility, melting point, thin layer chromatography, IR, 1HNMR spectral data and elemental analysis. All of the prepared derivatives were evaluated for their anti-inflammatory activity on wistar albino rats by following the carrageenan-induced Rat Hind Paw Edema model.

1 November 2016 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
SKSushil Kumar
Sushil Kumar
AWA.K. Wahi
A.K. Wahi
RSRanjit Singh
Ranjit Singh
A series of 2-[4-(aryl substituted) piperazin-1-yl]-N-benzylacetamides were synthesized and the target compounds (3a–j) were evaluated for atypical antipsychotic activity by studying apomorphine induced climbing behavior, 5-HTP induced head twitches behavior and catalepsy in mice. The physicochemical similarity of the target compounds with respect to standard drugs clozapine, ketanserin and risperidone was assessed by calculating from a set of physicochemical properties using software programs. The test compounds (3a–j) demonstrated good similarity values with respect to the standard drugs. Among them, compound 3b has emerged as an important lead compound showing potential atypical antipsychotic-like profile

1 January 2024 in Current Diabetes Reviews
Verified
Journal Article
Closed access
PDF file
SHShivam
Shivam
SKSushil Kumar
Sushil Kumar
AGAsheesh Kumar Gupta
Asheesh Kumar Gupta
Diabetes mellitus is a type of metabolic disorders. Various pharmaceutical interventions and animal models have been used to investigate the genetic, environmental, and etiological aspects of diabetes and its effects. In recent years for the development of ant-diabetic remedies, numerous novel genetically modified animals, pharmaceutical substances, medical techniques, viruses, and hormones have been developed to screen diabetic complications. A unique disease-treating drug with new properties is still being sought after. The current review tried to include all published models and cutting-edge techniques. Experimental induction of diabetes mellitus in animal models and in vitro methods are essential for advancing our knowledge, a thorough grasp of pathophysiology, and the creation of novel therapeutics. Animal models and in vitro techniques are necessary to develop innovative diabetic medications. New approaches and additional animal models are required for diabetes research to advance. This is particularly true for models produced via dietary modifications, which have various macronutrient compositions. In this article, we review the rodent models of diet-induced diabetic peripheral neuropathy, diabetic retinopathy, and diabetic nephropathy and critically compare the key characteristics of these micro-vascular complications in humans and the diagnostic criteria with the parameters used in preclinical research using rodent models, taking into consideration the potential need for factors that can accelerate or aggravate these conditions.

31 August 2025 in Oriental Journal of Chemistry
Verified
Journal Article
Open access
PDF file
AKAkhlesh Kumari
Akhlesh Kumari
SKSushil Kumar
Sushil Kumar
Chalcone and their benzotriazole derivatives originate from the nucleus ability to interpose into DNA base pairs, which inhibit lanosterol α-demethylase and DNA gyrase topoisomerase B. The active sites of topoisomerase B and lanosterol are the sites of molecular docking studies that provide comprehension of the intermolecular interactions for antimicrobial activity. Docking and ADMET properties of designed substituted benzaldehyde chalcones and their benzotriazoles using Schrodinger suit-2024 Maestro and SwissADME software programs against lanosterol α-demethylase and DNA gyrase topoisomerase B. C. albicans (lanosterol α-demethylase, PDB ID:4WMZ) and E. Coli (DNA gyrase topoisomerase B, PDB ID:1KZN) were selected for their respective binding affinities based on interaction patterns, GLIDE scores and docking scores. Compounds (7B1-7B7 and 9B1-9B3) showed strong binding interactions, and their ability to inhibit lanosterol α-demethylase (4WMZ) and DNA gyrase topoisomerase B (1KZN) for antimicrobial activity. Among the compounds, 9B1, 9B2, 9B3, and 7B1 have good binding affinity with GLIDE scores in the range of -10.655 to -10.154 against C. albicans and 7B1, 7B2 and 9B2 have good binding affinity with GLIDE score in range of -5.613 to -5.083 against E. coli when compared with the standard Fluconazole (-6.58) and Amoxicillin (-5.29). Test compounds showed good ADMET properties and similarity with respect to standard drugs. Molecular docking studies and in silico ADMET screening of new chalcones and their benzotriazole derivatives could be used as inhibitors of lanosterol α-demethylase (4WMZ) and DNA gyrase topoisomerase B (1KZN). Additional in-vitro and in-vivo research could confirm its potential as antimicrobials.